Novel class of pain drugs based on antagonism of NGF

FF Hefti, A Rosenthal, PA Walicke, S Wyatt… - Trends in …, 2006 - cell.com
Nerve growth factor (NGF) was identified originally as a survival factor for sensory and
sympathetic neurons in the developing nervous system. In adults, NGF is not required for …

NGF/TrkA signaling as a therapeutic target for pain

M Hirose, Y Kuroda, E Murata - Pain Practice, 2016 - Wiley Online Library
Nerve growth factor (NGF) was first discovered approximately 60 years ago by Rita Levi‐
Montalcini as a protein that induces the growth of nerves. It is now known that NGF is also …

Antagonism of nerve growth factor-TrkA signaling and the relief of pain

PW Mantyh, M Koltzenburg, LM Mendell… - …, 2011 - pmc.ncbi.nlm.nih.gov
Nerve growth factor (NGF) was originally discovered as a neurotrophic factor essential for
the survival of sensory and sympathetic neurons during development. However in the adult …

Targeting nerve growth factor in pain: what is the therapeutic potential?

JJ Watson, SJ Allen, DD Dawbarn - BioDrugs, 2008 - Springer
Chronic pain presents a huge economic and social burden, with existing treatments largely
unable to satisfy medical needs. Recently, studies have shown that nerve growth factor …

Neuropathic pain: emerging treatments

A Dray - British journal of anaesthesia, 2008 - academic.oup.com
Neuropathic pain remains one of the most challenging of all neurological diseases and
presents a large unmet need for improved therapies. Many mechanistic details are still …

Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target

P Ochodnický, CD Cruz, N Yoshimura… - Neurourology and …, 2011 - Wiley Online Library
In the last two decades, nerve growth factor (NGF), initially described as a prototypical
trophic factor in the development of sensory and sympathetic innervation, has emerged as a …

Arthritis and pain. Future targets to control osteoarthritis pain

A Dray, SJ Read - Arthritis research & therapy, 2007 - Springer
Clinical presentation of osteoarthritis (OA) is dominated by pain during joint use and at rest.
OA pain is caused by aberrant functioning of a pathologically altered nervous system with …

Nerve growth factor in cancer cell death and survival

NH Molloy, DE Read, AM Gorman - Cancers, 2011 - mdpi.com
One of the major challenges for cancer therapeutics is the resistance of many tumor cells to
induction of cell death due to pro-survival signaling in the cancer cells. Here we review the …

Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor

JK Eibl, BC Strasser, GM Ross - Neurochemistry international, 2012 - Elsevier
Nerve growth factor (NGF) is critical for the development and maintenance of sympathetic
and sensory neurons in the developing nervous system, including nociceptors. In the adult …

Targeting the nerve growth factor (NGF) pathway in drug discovery. Potential applications to new therapies for chronic pain

BH Norman, JS McDermott - Journal of Medicinal Chemistry, 2017 - ACS Publications
The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of
chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the …